Edward Chesney

7.1k total citations · 2 hit papers
77 papers, 4.8k citations indexed

About

Edward Chesney is a scholar working on Psychiatry and Mental health, Global and Planetary Change and Pharmacology. According to data from OpenAlex, Edward Chesney has authored 77 papers receiving a total of 4.8k indexed citations (citations by other indexed papers that have themselves been cited), including 21 papers in Psychiatry and Mental health, 21 papers in Global and Planetary Change and 15 papers in Pharmacology. Recurrent topics in Edward Chesney's work include Marine and fisheries research (21 papers), Schizophrenia research and treatment (15 papers) and Cannabis and Cannabinoid Research (15 papers). Edward Chesney is often cited by papers focused on Marine and fisheries research (21 papers), Schizophrenia research and treatment (15 papers) and Cannabis and Cannabinoid Research (15 papers). Edward Chesney collaborates with scholars based in United Kingdom, United States and Italy. Edward Chesney's co-authors include Seena Fazel, Guy M. Goodwin, Philip McGuire, Dominic Oliver, Paolo Fusar‐Poli, Glyn Lewis, Anthony S. David, Jonathan Rogers, Michael S. Zandi and Thomas Pollak and has published in prestigious journals such as The Lancet, SHILAP Revista de lepidopterología and Journal of Geophysical Research Atmospheres.

In The Last Decade

Edward Chesney

71 papers receiving 4.6k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Psychiatric and neuropsychiatric presentations associated with severe coronavirus infections: a systematic review and meta-analysis with comparison to the COVID-19 pandemic

2020 1.6k citations Edward Chesney, Dominic Oliver et al. profile →
Risks of all-cause and suicide mortality in mental disorders: a meta-review

2014 1.4k citations Edward Chesney, Guy M. Goodwin et al. World Psychiatry profile →

Peers

Countries citing papers authored by Edward Chesney

Since Specialization

Citations

This map shows the geographic impact of Edward Chesney's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Edward Chesney with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Edward Chesney more than expected).

Fields of papers citing papers by Edward Chesney

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Edward Chesney. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Edward Chesney. The network helps show where Edward Chesney may publish in the future.

Co-authorship network of co-authors of Edward Chesney

This figure shows the co-authorship network connecting the top 25 collaborators of Edward Chesney. A scholar is included among the top collaborators of Edward Chesney based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Edward Chesney. Edward Chesney is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Are reasons for first using cannabis associated with subsequent cannabis consumption (standard THC units) and psychopathology? 2025 ·BMJ Mental Health ·Edoardo Spinazzola, (unknown), (unknown), Giulia Trotta, Edward Chesney, (unknown), Luis Alameda, Brian Leung, (unknown), Andrea Quattrone, Diego Quattrone, Erika Castrignanò, Kim Wolff, Robin Murray, Tom P. Freeman, Marta Di Forti	0
2	Naloxone dosing in the era of synthetic opioids: Applying the Goldilocks principle 2025 ·Addiction ·(unknown), Edward Chesney, Joanne Neale, Nicola Metrebian, Nicola J. Kalk, Arne Kristian Skulberg, Paul Dietze, Martin P. Smith, John Strang	4
3	Identification of menstrual psychosis cases using electronic health records 2025 ·The British Journal of Psychiatry ·Thomas J. Reilly, Edward Chesney, Adam Al‐Diwani, Amelia Jewell, Alexis E. Cullen, Dominic Oliver, Philip McGuire	0
4	Recent Innovations to Detect and Intervene to Prevent Opioid Overdose Deaths 2025 ·British Journal of Hospital Medicine ·John Strang, Elizabeth Appiah‐Kusi, Edward Chesney, (unknown), (unknown), Will Lawn, (unknown)	0
5	Does cannabidiol reduce the adverse effects of cannabis in schizophrenia? A randomised, double-blind, cross-over trial 2025 ·Neuropsychopharmacology ·Edward Chesney, Dominic Oliver, (unknown), (unknown), (unknown), (unknown), Alex M. Dickens, (unknown), Matilda Kråkström, (unknown), Matej Orešič, Will Lawn, (unknown), Tom P. Freeman, Amir Englund, John Strang, Philip McGuire	1
6	Psychosis associated with cannabis withdrawal: systematic review and case series 2024 ·The British Journal of Psychiatry ·Edward Chesney, Thomas J. Reilly, Fraser Scott, (unknown), (unknown), (unknown), Dominic Oliver, Philip McGuire	3
7	Novel Lipid Formulation Increases Absorption of Oral Cannabidiol (CBD) 2024 ·Pharmaceutics ·Edward Chesney, Ndaba Mazibuko, Dominic Oliver, Amedeo Minichino, (unknown), (unknown), Thomas J. Reilly, (unknown), Matilda Kråkström, Alex M. Dickens, Matej Orešič, Eric M. Lynch, Gregory Stoloff, Mitul A. Mehta, Philip McGuire	1
8	Why we need to pursue both universal and targeted prevention to reduce the incidence of affective and psychotic disorders: Systematic review and meta-analysis 2024 ·Neuroscience & Biobehavioral Reviews ·(unknown), Dominic Oliver, (unknown), Joaquim Raduà, (unknown), (unknown), (unknown), (unknown), (unknown), Edward Chesney, (unknown), Andrea De Micheli, (unknown), Valentina Floris, Gonzalo Salazar de Pablo, Paolo Fusar‐Poli	4
9	Point of care assay for blood aripiprazole concentrations: development, validation and utility 2023 ·The British Journal of Psychiatry ·(unknown), David Taylor, Ana Catalán, (unknown), Edward Chesney, Thomas J. Reilly, Irina Baburina, (unknown), Luiz Dratcu, Robert Harland, Salvatore J. Salamone, Philip McGuire	1
10	The acute effects of cannabis with and without cannabidiol in adults and adolescents: A randomised, double‐blind, placebo‐controlled, crossover experiment 2023 ·Addiction ·Will Lawn, (unknown), Claire Mokrysz, Anna Borissova, (unknown), Kat Petrilli, Michael Bloomfield, (unknown), Daniel L. Hall, (unknown), Simiao Wang, Amir Englund, Edward Chesney, Matthew B. Wall, Tom P. Freeman, Valerie H. Curran	24
11	Cannabidiol does not attenuate acute delta‐9‐tetrahydrocannabinol‐induced attentional bias in healthy volunteers: A randomised, double‐blind, cross‐over study 2023 ·Addiction ·Dominic Oliver, Amir Englund, Edward Chesney, (unknown), Jack Wilson, (unknown), (unknown), John Hodsoll, John Strang, Robin Murray, Tom P. Freeman, Paolo Fusar‐Poli, Philip McGuire	3
12	Assessing Cannabis Use in People with Psychosis 2023 ·Cannabis and Cannabinoid Research ·Edward Chesney, Will Lawn, Philip McGuire	5
13	Does cannabidiol make cannabis safer? A randomised, double-blind, cross-over trial of cannabis with four different CBD:THC ratios 2022 ·Neuropsychopharmacology ·Amir Englund, Dominic Oliver, Edward Chesney, (unknown), Jack Wilson, (unknown), Andrea De Micheli, John Hodsoll, Paolo Fusar‐Poli, John Strang, Robin Murray, Tom P. Freeman, Philip McGuire	69
14	Effects of Cannabidiol and Delta-9-Tetrahydrocannabinol on Plasma Endocannabinoid Levels in Healthy Volunteers: A Randomized Double-Blind Four-Arm Crossover Study 2022 ·Cannabis and Cannabinoid Research ·(unknown), Amir Englund, Edward Chesney, Dominic Oliver, Jack Wilson, (unknown), Alex M. Dickens, Matej Orešič, (unknown), John Hodsoll, Amedeo Minichino, John Strang, Robin Murray, Tom P. Freeman, Philip McGuire	7
15	Stone CrabMenippespp. Populations on Louisiana's Nearshore Oil and Gas Platforms: Higher Density and Size at Maturity on a Sand Shoal 2017 ·Transactions of the American Fisheries Society ·(unknown), (unknown), Edward Chesney, Donald M. Baltz, Brian D. Marx	7
16	Toxicity of weathered Deepwater Horizon oil to bay anchovy (Anchoa mitchilli) embryos 2017 ·Ecotoxicology and Environmental Safety ·Kathryn A. O’Shaughnessy, Heather P. Forth, Ryan Takeshita, Edward Chesney	16
17	Risks of all-cause and suicide mortality in mental disorders: a meta-review breakdown → 2014 ·World Psychiatry ·Edward Chesney, Guy M. Goodwin, Seena Fazel	1375
18	Application of mercury isotopes for tracing trophic transfer and internal distribution of mercury in marine fish feeding experiments 2013 ·Environmental Toxicology and Chemistry ·Sae Yun Kwon, Joel D. Blum, (unknown), Edward Chesney	86
19	Mercury bioaccumulation in coastal and migratory foodwebs in the Gulf of Mexico 2009 ·Geochimica et Cosmochimica Acta Supplement ·David B. Senn, Edward Chesney, Joel D. Blum, James P. Shine	1
20	Seasonal distribution, abundance and diversity of demersal fishes in the inner Ría de Arosa, NW Spain 1979 ·Estuarine Coastal and Shelf Science ·Edward Chesney, (unknown)	4

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact